1
Clinical Trials associated with Human fetal-derived Neural Stem Cells(Ospedale San Raffaele)Neural Stem Cell Transplantation in Multiple Sclerosis Patient: a Phase I Study
This is a phase I study evaluating the feasibility, safety and tolerability of intrathecally administered human Neural Stem Cells (hNSCs), at an escalating dose ranging from 0.7x10^6±10% cells to 5.7x10^6±10% cells/kg of body weight, in patients affected by Progressive Multiple Sclerosis
100 Clinical Results associated with Human fetal-derived Neural Stem Cells(Ospedale San Raffaele)
100 Translational Medicine associated with Human fetal-derived Neural Stem Cells(Ospedale San Raffaele)
100 Patents (Medical) associated with Human fetal-derived Neural Stem Cells(Ospedale San Raffaele)
100 Deals associated with Human fetal-derived Neural Stem Cells(Ospedale San Raffaele)